Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections.
about
Laboratory diagnosis of Clostridium difficile infection can molecular amplification methods move us out of uncertainty?Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study).Effect of ceftaroline on normal human intestinal microflora.Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis.Development of TaqMan-based quantitative PCR for sensitive and selective detection of toxigenic Clostridium difficile in human stools.Comparison of strain typing results for Clostridium difficile isolates from North America.Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimensCost and Impact on Patient Length of Stay of Rapid Molecular Testing for Clostridium difficileIndeterminate tcdB using a Clostridium difficile PCR assay: a retrospective cohort studyClinical characteristics of patients who test positive for Clostridium difficile by repeat PCR.Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.Characteristics and Antibiotic Use Associated With Short-Term Risk of Clostridium difficile Infection Among Hospitalized PatientsClostridium difficile infections in China.Alerting physicians during electronic order entry effectively reduces unnecessary repeat PCR testing for Clostridium difficile.Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants.Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis.Epidemiology, diagnosis and treatment of Clostridium difficile infection.Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).Clostridium colitis: challenges in diagnosis and treatment.Current knowledge on the laboratory diagnosis of Clostridium difficile infection.Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile diseaseEvaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.Comparison of GenomEra C. difficile and Xpert C. difficile as confirmatory tests in a multistep algorithm for diagnosis of Clostridium difficile infection.Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection.Is repeat PCR needed for diagnosis of Clostridium difficile infection?Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system.Accuracy of Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection: A meta analysis.Presumptive identification of Clostridium difficile strain 027/NAP1/BI on Cepheid Xpert: interpret with caution.Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR.Characterization of Clostridium difficile Strains Isolated from Patients with C. difficile-associated Disease in Korea.Editorial commentary: Changing epidemiology of Clostridium difficile and emergence of new virulent strains.
P2860
Q26827536-89632AA0-CB96-4F7E-BF85-EC1F45406043Q33571646-567BF950-CA7D-425A-A617-F5E336D1F3D5Q33826455-0C99AB46-33D2-4FF4-B856-34878A8F7C92Q34190375-85148779-A752-4223-9DB3-C7EE3E13D645Q34213457-9EAA46FC-4072-448C-8E6B-12109E3678D9Q34435291-D1E28EB2-E14F-4FA4-9506-763D73EEBE09Q34627447-5F078801-1BCC-4EBE-B207-61D16348B918Q34628889-064BB7D1-1B08-490F-85CD-EE7DD0CE658CQ34726112-257FC01D-5E5D-4920-B031-82A34EACE9A1Q34832564-D33FB02C-4662-4946-925E-C69821035244Q35035947-C8B3AA65-E9F0-4545-9C5D-BC674D69F673Q35140090-A79442DD-C098-4933-B773-B0D03F169E9DQ36240111-827B8119-E474-49CA-89CD-6E9F865F1E1FQ36681933-75F64B32-BF28-4401-9F39-8D34EA949CE7Q37470515-E36BFBB3-BDE2-4604-95B5-985E3309BAB3Q37546536-E0CCBA54-C80E-4F13-A04B-AECA395C7797Q37663683-0F1C4548-B6AF-4D8C-BE4B-F393BEFA2A70Q38024184-2946D28F-6849-4676-B974-134BB4529CF9Q38068605-56619082-8D01-4E8C-A6DF-BDE0173B4C46Q38080794-9F433578-C124-4529-B1F5-5A3E924712EEQ38247224-646DE13F-1BA6-4712-B335-298A9D0B14C1Q39188881-DE88D012-7E6E-432C-AD9C-437E17028E23Q41015032-7BA4E9C4-C85D-4E6F-B669-39538FB157EEQ41428486-ACF9C26F-546D-488D-B9F9-B5C0EA62BFE3Q41665158-753A378C-DF66-4A27-8A79-E0FEE7F984BBQ41850630-B8B3760C-2447-41E0-BF39-9C8223B006CEQ42074690-34BC422E-6135-4CAD-ABC6-44F7E09630DBQ42571326-156D631A-1ABE-4C1E-8EBE-4A388F41D3EFQ42708367-BB0F2F74-BD64-47A6-A56B-3137149CF751Q42931684-DA6F0167-0EF6-4FAC-96C0-F3B9638B1430Q43682898-A2C6CACD-895A-4545-BA06-B663DCE5CEB3Q47094068-556963A2-ECF1-4928-80AD-A562B4E5DBF9Q48319188-154ADB34-D5B9-4265-BEA6-31849A6B8219
P2860
Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Comparison of a commercial mul ...... stridium difficile infections.
@en
Comparison of a commercial mul ...... stridium difficile infections.
@nl
type
label
Comparison of a commercial mul ...... stridium difficile infections.
@en
Comparison of a commercial mul ...... stridium difficile infections.
@nl
prefLabel
Comparison of a commercial mul ...... stridium difficile infections.
@en
Comparison of a commercial mul ...... stridium difficile infections.
@nl
P2093
P2860
P356
P1476
Comparison of a commercial mul ...... ostridium difficile infections
@en
P2093
Carl Erik Nord
Haihui Huang
P2860
P304
P356
10.1128/JCM.01280-09
P407
P577
2009-09-09T00:00:00Z